Overview


According to FutureWise analysis, the market for Viral Vector and Plasmid DNA Testing is expected to grow with a CAGR of 25.8% over the forecast period 2024-2032, and reach a market value of US$ 1.44 Billion by 2031. 

Viral Vector and Plasmid DNA Testing Services ensure the safety, efficacy, and quality of gene therapy products and other biopharmaceuticals. These services encompass a comprehensive range of analytical techniques and assays to assess the characteristics and integrity of viral vectors and plasmid DNA constructs. These serve as essential components in gene therapy development.

Viral vectors, often derived from lentivirus or adeno-associated virus (AAV), are engineered to deliver therapeutic genes into target cells. Plasmid DNA, conversely, is a crucial tool in genetic engineering, allowing for the replication and expression of genes of interest. Both play pivotal roles in the production and delivery of gene therapies, making their rigorous testing imperative. Testing services for viral vectors and plasmid DNA encompass a multitude of assessments. These include evaluating vector potency, ensuring genetic stability, and confirming the absence of potential contaminants, such as replication-competent viruses. Techniques like polymerase chain reaction (PCR), next-generation sequencing (NGS), and analytical ultracentrifugation are employed to scrutinize these constructs meticulously. Additionally, sterility, purity, and identity tests are conducted to meet regulatory standards and ensure product safety.

FutureWise Market Research has published a report that provides an insightful analysis of Viral Vector and Plasmid DNA Testing Services Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Viral Vector and Plasmid DNA Testing Services Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Charles River Laboratories, Inc.,
  • WuXi AppTec Co., Ltd.
  • Cobra Biologics and Pharmaceutical Services
  • Merck KgaA
  • Lonza
  • Eurofins Scientific
  • FinVector Vision Therapies
  • Advanced Bioscience Laboratories, Inc.
  • Takara Bio Inc.
  • ViruSure GmbH
  • Genezen Laboratories
  • Akron Biotech.
  • Catalent, Inc
  • AcuraBio.
  • CATUG Biotechnology

(Note: The list of the major players will be updated with the latest market scenario and trends)

On the driver side, the growing interest and investment in gene therapy for treating genetic disorders and other diseases is a significant factor for the viral vector and plasmid DNA testing services market. These services are crucial for ensuring the safety and efficacy of gene therapy products. Continuous advancements in biotechnology and molecular biology techniques have led to the development of increasingly complex viral vectors and plasmid DNA constructs. Testing services are required to assess their quality, integrity, and safety. The substantial investment in research and development by pharmaceutical and biotechnology companies and academic institutions is driving the demand for testing services. This is particularly true for companies involved in gene therapy development. Regulatory bodies, such as the FDA and EMA, have established strict guidelines for the quality and safety of gene therapy products. This necessitates comprehensive testing of viral vectors and plasmid DNA before clinical trials and commercialization, propelling the market growth.

However, testing viral vectors and plasmid DNA involves complex methodologies and techniques, often requiring specialized equipment and expertise. This can lead to challenges in conducting thorough and accurate testing. The testing services for viral vectors and plasmid DNA can be costly, particularly for comprehensive and high-throughput analyses. This cost can be a barrier for smaller biotech companies and academic research labs, hampering the market growth.

By Service Type

  • Safety
  • Genetic Characterization
  • Purity
  • Identity
  • Potency

By End User

  • Pharmaceutical and Biotechnology Industries
  • Research Organizations

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the presence of key players in the region who are focused on facility expansions to increase production and research & development activities; robust healthcare infrastructure is driving the market in this region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Viral Vector and Plasmid DNA Testing Services Market By Service Type, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Viral Vector and Plasmid DNA Testing Services Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Viral Vector and Plasmid DNA Testing Services Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Viral Vector and Plasmid DNA Testing Services Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Viral Vector and Plasmid DNA Testing Services Market, By Service Type Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Safety
        2. Genetic Characterization
        3. Purity
        4. Identity
        5. Potency

  • 8.  Viral Vector and Plasmid DNA Testing Services Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Pharmaceutical and Biotechnology Industries
        2. Research Organizations

  • 9.  North America Viral Vector and Plasmid DNA Testing Services Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 10.  Latin America Viral Vector and Plasmid DNA Testing Services Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 11.  Europe Viral Vector and Plasmid DNA Testing Services Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 12.  Asia Pacific Viral Vector and Plasmid DNA Testing Services Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 13.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 14.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 15.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Charles River Laboratories, Inc.
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. WuXi AppTec Co., Ltd.
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Cobra Biologics and Pharmaceutical Services
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Merck KgaA
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Lonza
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Eurofins Scientific
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. FinVector Vision Therapies
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Advanced Bioscience Laboratories, Inc.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Takara Bio Inc.
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. ViruSure GmbH
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Genezen Laboratories
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Akron Biotech
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Catalent, Inc
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. AcuraBio
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. CATUG Biotechnology
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview

  • 16.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.  FutureWise SME Key Takeaway Points for Client

    •      


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11